Santa Rosa Post Acute: Diabetes Emergency Failures - CA
Glucagon is the emergency medication kept in nursing facilities for exactly this situation. A resident whose blood glucose crashes below safe levels and can no longer swallow sugar needs an injection. The American Diabetes Association's own 2025 guidelines for healthcare professionals state it plainly: glucagon is indicated when people are unable to consume carbohydrates by mouth, and clinicians should prescribe it for all patients on insulin. Non-healthcare professionals can safely administer it. The barriers to using it are supposed to be low.
At Santa Rosa Post Acute, inspectors found the barrier was the facility itself.
The inspection, conducted December 26, 2025, documented failures in how the facility handled severe hypoglycemia — a condition the ADA categorizes at its most dangerous level, Level 3, when a patient shows altered mental or physical status regardless of what the glucometer actually reads. Level 2 begins when blood glucose drops below 54 mg/dL. Both require immediate intervention.
The facility's own hypoglycemia policy, revised as recently as March 2025, spelled out the correct response: if a resident is hypoglycemic and unresponsive, administer 1 mg of glucagon subcutaneously. The policy existed. The medication is supposed to be on hand. Inspectors found the problem was getting to it.
The inspection report identified deficiencies in documentation as well, and the two failures are connected. The facility's charting policy, last revised in July 2017, requires that all services provided to a resident be documented in the medical record, including objective observations, treatments performed, changes in condition, and any unusual findings. The medication administration policy, revised April 2019, requires that nurses initial the medication administration record after giving each medication, before moving on to the next.
When those documentation requirements aren't followed during a fast-moving emergency, the record of what happened, when it happened, and whether the right intervention occurred becomes impossible to reconstruct.
The facility's change-of-condition policy adds another layer. When a resident experiences a significant decline, one that affects more than one area of health and won't resolve without staff intervention, nurses are required to notify the physician and document everything in the medical record. A resident going unresponsive from hypoglycemia qualifies. The ADA's guidance is explicit that Level 2 or Level 3 hypoglycemia should trigger a reevaluation of the entire treatment plan.
Blood glucose meters, the inspection materials noted, are accurate within roughly 15 to 20 percent of the actual reading under FDA standards. That margin matters in borderline cases. It means a reading that looks like it's just above the danger threshold could still represent genuine crisis for a resident whose symptoms suggest otherwise. Facilities are supposed to treat the patient in front of them, not just the number on the screen.
Inspectors classified the violations as causing minimal harm or the potential for actual harm, and noted that few residents were affected. That classification sits at the lower end of the federal harm scale, but it does not mean nothing happened. It means the worst outcome, for now, was avoided.
Glucagon preparations that don't require mixing before use are the preferred form, according to the ADA's 2025 guidelines. They exist specifically to reduce the time between a crisis and treatment. The seconds spent reconstituting an older formulation, or locating a kit that staff couldn't reach quickly enough, are seconds a resident with altered consciousness doesn't have.
The kit was there. The policy was written. The medication existed. What inspectors found at Santa Rosa Post Acute was the gap between what a facility puts on paper and what actually happens when a resident stops responding.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Santa Rosa Post Acute from 2025-12-26 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: August 23, 2026 · Our methodology
SANTA ROSA POST ACUTE in SANTA ROSA, CA was cited for violations during a health inspection on December 26, 2025.
Glucagon is the emergency medication kept in nursing facilities for exactly this situation.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.